New appointment at Cubist Pharmaceuticals
This article was originally published in Scrip
Cubist Pharmaceuticals (US) has named Dr Santosh Vetticaden senior vice-president of clinical development and chief medical officer. Dr Vetticaden has more than 22 years' experience as a researcher and medical professional. He has been consulting since leaving his position as senior vice-president and chief medical officer at Maxygen, a position he held from February 2007 to August 2008. Before that, he was vice-president of clinical research at Scios, a subsidiary of Johnson & Johnson.